Long-term outcome of acute tubular necrosis: A contribution to its natural history  by Liaño, F. et al.
Long-term outcome of acute tubular necrosis:
A contribution to its natural history
F Lian˜o1,2, C Felipe1, MT Tenorio1, M Rivera1, V Abraira3, JM Sa´ez-de-Urturi4, J Ocan˜a1, C Fuentes5
and S Severiano5
1Nephrology Department, Hospital Universitario Ramo´n y Cajal, Madrid, Spain; 2Department of Medicine, School of Medicine,
Universidad de Alcala´, Alcala´ de Henares, Spain; 3Department of Clinical Biostatistics, Hospital Universitario Ramo´n y Cajal, Madrid,
Spain; 4Clinical Documentation and Archives Department, Hospital Universitario Ramo´n y Cajal, Madrid, Spain and 5Department of
Health Information of the Community of Madrid, Madrid, Spain
As long-term outcome studies of acute renal failure (ARF) are
scarce and non-homogeneous, we studied 187 consecutive
acute tubular necrosis (ATN) patients without previous
nephropathies, discharged alive from our hospital between
October 77 and December 92 and followed-up until
December 99 (range 7–22 years; median 7.2). Variables
were analyzed at the time of the acute episode and during
follow-up. In 2000–2001 a clinical evaluation was made in 58
of the 82 patients still alive. Ten patients were lost to follow-
up and 95 died. In 59% death was related with the disease
present when the ATN developed. Kaplan–Meir survival curve
showed 89, 67, 50, and 40% at 1, 5, 10, and 15 years,
respectively, after discharge. Survival curves were
significantly better (log-rank Po0.001) among the youngest,
those surviving a polytrauma, those without comorbidity and
surprisingly those treated in intensive care units. The
proportional Cox model showed that age (hazard ratio (HR)
1.04 per year of age; P¼ 0.000), presence of comorbid factors
(HR 4.29; P¼ 0.006), surgical admission (HR 0.45; P¼ 0.000),
and male sex (HR 1.72; P¼ 0.020) were the variables
associated with long-term follow-up. In the evaluated
patients renal function was normal in 81%. Long-term
outcome after ARF depends on absence of co-morbid factors,
cause of initial admission and age. Although the late
mortality rate is high and related with the original disease,
renal function is adequate in most patients.
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During the last half century, studies concerning long-term
survival after an acute renal failure episode (ARF) have been
few and non-homogeneous1–10 with a follow-up period
ranging between 65 and 372 months.1 Only four studies
include more than a hundred patients in their long-term
studied population.1,2,9,10 Additionally, with the exception of
age on the functional outcome,4,11,12 few variables that could
potentially influence either the functional or long-term
outcome of patients surviving an ARF episode have been
studied. Consequently, the influence that an ARF episode has
on long-term outcome of the surviving patients is almost
unknown. However, most of the medical community
consider, without any contrasted evidence, that ARF has no
influence on the long-term outcome of surviving patients.
To clarify these aspects, we developed a protocol to study
the factors that could affect the personal and functional long-
term outcomes of patients who, having previously had a
normal kidney function, developed and survived acute
tubular necrosis (ATN), which is both the most usual and
severe form of ARF.5,13 In this article we analyze the long-
term survival of 187 ATN patients consecutively discharged
alive at Ramo´n y Cajal Hospital between 1977 and 1992. They
all had a potential minimal observational period of 7 years.
RESULTS
Of an initial population of 413 ARF cases, the 187 surviving
patients (45%) constituted the population analyzed (Table 1).
Only 10 of the 187 patients were lost to follow-up
(95%follow-up rate). The remaining 177 patients were
followed between 6 months and 22 years. Fifty percent of
the patients had a follow-up of 7.2 years (P25: 2.0 years and
P75:11.6 years). The probability of these patients being alive
10 years after discharge was 50%. (Figure 1).
All the variables given in ‘Materials and Methods’ were
analyzed using the Kaplan–Meir curves. There were no
differences in the survival curves (not shown) in relation with
sex, ATN etiology, individual severity index (ISI), need of
dialysis, ARF functional severity, presence/absence of oliguria
or the degree of renal function at discharge.
Survival rates at 10 years for patients younger than 31,
between 31 and 50, 51 and 70, and older than 70 years of age
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were 64, 78, 50, and 18%, respectively. The survival curves of
these four groups of patients had statistically significant
differences (log-rank P¼ 0.000) (Figure 2a). There were no
statistical differences between the survival curves of the group
of patients younger than 31 years and that of patients with
ages ranging between 31 and 50 years (P¼ 0.172). The
comparisons between the survival curves of the other age
groups are shown in Figure 2a. A similar analysis grouping
the patients by decades gave similar results. The survival
curve of each decade was worse than that of the preceding
one with the exception of the patients younger than 21 who
had a worse survival curve than that of the patients with ages
ranging between 21 and 30 years of age (not shown).
The probability of survival at 10 years after discharge for
patients having a trauma, surgical or medical admission was
84, 53, and 44%, respectively. The survival curves of these
three different types of admission were statistically different
(log-rank P¼ 0.041) (Figure 2b).
The survival curve of patients without comorbid factors
was significantly better (log-rank P¼ 0.000) than that of
patients with associated comorbid processes (Figure 2c). At
10 years after discharge, the survival rate was 85% in the first
group and 42% in the second.
When we analyzed individually the survival curves of the
different comorbid pathologies considered in this study, no
statistical difference was observed among them (data not
shown). This could be due to the small number of patients in
each subgroup. Also, the fact that 48% of the patients had at
least two comorbid factors could have contributed to these
figures.
During the follow-up 95 patients died. Ninety-one of
them (97%) had comorbidity factors at the time of ARF. The
causes of death among the four patients without comorbidity
factors were an acute myocardial infarction, urinary sepsis
associated with a permanent urinary catheter, drug overdose,
and one unknown. At the time of death, two of these patients
had normal renal function and the others had mild renal
insufficiency.
The survival curve of patients treated in an intensive care
unit (ICU) setting was significantly better (log-rank
P¼ 0.002) than that of patients treated in other hospital
areas. At 10 years the survival rate was 61 and 42% for ICU
and non-ICU patients, respectively (Figure 2d).
Long-term outcome, assessed by the survival curves, was
better among those patients who at the time of hospital
discharge had completely recovered their renal function than
among those with only partial recovery (log-rank P¼ 0.028)
Table 1 | Characteristics of the survivor patients at the
moment of the acute tubular necrosis renal failure episode
Patients
(No=187) (%)
Age/years 57.8716.2
Gender (female/male) 63/124 34/66
Comorbidity factors (no/yes) 35/152 19/81
Type of admission
Medical 95 51
Surgical 81 43
Trauma 11 6
ATN ethiology
Nephrotoxic 97 52
Sepsis 26 14
Medical 32 17
Surgical 32 17
Severity Index (SI) 0.3170.2
ARF functional severity
Mild 20 11
Moderate 79 42
Severe 88 47
Type of ARF
Oliguric 72 39
Non oliguric 115 61
Dialysis
Yes 57 30
No 130 70
ICU admission
Yes 80 43
No 107 57
ICU stay (days) 14.7714.0
Recovery of renal function with respect to serum creatinine at admission
Total recovery 78 42
Partial recovery 107 57
No recovery 2 1
Renal function at discharge
Normal renal function 78 42
Mild renal insufficiency 64 13
Moderate renal insufficiency 39 21
Severe renal insufficiency 6 3
Dialysis 0
Final serum creatinine (mg/dl) 1.770.7
Length of admission (days) 53.9736.9
Length of nephrological care (days) 18.9713.6
ARF, acute renal failure episode; ATN, acute tubular necrosis; ICU, intensive care unit;
SI, severity index.
Continuous variables are expressed as mean7s.d.
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Figure 1 | Kaplan–Meier survival curve of the patients discharged
alive after an ATN episode.
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(figure not shown). The survival rates at 10 years were 60% in
the first group and 43% in the second.
Cox proportional model analysis showed that the
independent variables predicting the long-term outcome
were: age, gender, presence of comorbidity factors and cause
of initial admission (Table 2).
Indeed, according to this analysis, the risk of death
increased 4% per year of age. Also, the presence of
comorbidity factors when the ARF developed implied a
fourfold higher relative risk of death than that observed
among patients without comorbidity problems.
In general, the type of admission had important predictive
significance (P¼ 0.000) on long-term survival of ATN
patients. Analyzing the three admission groups, and using
the risk of mortality of the medical admissions as reference
value, the hazard ratios (HRs) for surgical (HR 0.45;
P¼ 0.000) and trauma admissions (HR 0.42; P¼ 0.397) were
lower (Table 2). There was no difference in the HR for
mortality between medical and trauma groups.
Male long-term outcome was poorer than that of females
(HR 1.72; P¼ 0.020).
The cause of death during the follow-up was analyzed in
86 of the 95 deaths. Mortality was attributed to one isolated
cause in 80.2% of the cases. It should be stressed that the
death of 59% of the patients was due to the initial disease
present when the ARF episode developed.
Although a profound analysis of the long-term outcome
of the kidney function is not the aim of this article, some data
is given. Serum creatinine concentration (SCr) (mean7s.d.)
at hospital discharge (1.770.7 mg/dl) decreased until the
sixth month (1.370.5 mg/dl), after which it remained
reasonably stable during the 10 years of follow-up analyzed.
During the follow-up three patients (1.7%), with severe
comorbidity factors and age at the ATN episode ranging
between 26 and 53 years, required chronic hemodialysis at 6,
11, and 12 years after discharge.
Last clinical evaluation
During 2000–2001, 58 of the 82 patients alive at the end of
the study period agreed to have a complete check-up. The
mean time since the ARF episode was 11.9 years. Fifty percent
of the patients had a follow-up period of 10.8 years (P25: 8.5
and P50: 14.8 years). Mean age at the moment of the last
clinical evaluation was 61.4714.0 years (range, 24–86 years).
Males (n¼ 34) and females (n¼ 24) were similar in age.
Sixteen of the evaluated patients (28.5%) had no
comorbidity factors. Although the group of patients with
comorbidity factors was older (63.4713.3 years) than that of
patients without comorbidity factors (56.8718.1 years), this
difference was not statistically significant (P¼ 0.132). At this
time, 46 patients had normal renal function (at hospital
discharge functional situation was: 27 normal renal function;
13 mild renal insufficiency and six moderate or severe renal
insufficiency), nine patients had mild renal failure (at
hospital discharge: two had normal renal function; four mild
renal insufficiency, and three moderate or severe renal
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Figure 2 | Kaplan–Meier survival curves according to: (a) age; (b) the type of hospital admission; (c) the presence or absence of co-
morbid conditions, and (d) the need or not of intensive care treatment during the ARF episode.
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insufficiency), two patients had moderate renal failure (at
hospital discharge one was in the same situation and the
other had mild renal insufficiency) and finally one patient
was in periodic hemodialysis (at hospital discharge he had
moderate renal failure). With the exception of the patient on
chronic hemodialysis, the analytical data of these patients are
shown in Table 3.
All the inhabitantsX15 years of age living in Madrid on 1
January 1978 were studied as a cohort. The survival curve of
this cohort is shown in Figure 3a and compared graphically
with that of the patients who survived an ATN episode. It can
be clearly appreciated that the slope of the curve of patients
having had ARF is worse than that observed in the general
population. A similar analysis, sub-classifying the patients
and the general population in three subgroups of age, also
demonstrated that the poorer vital expectative of patients
with ARF in comparison with the general population was not
conditioned by an age effect (Figure 3b).
DISCUSSION
Methodologically, as the ARF syndrome has many etiologies,
we limited the study only to patients having ATN owing to
the fact that: (1) ATN is the paradigmatic form of the
syndrome;14 (2) it is the most frequent type of ARF observed
in developed countries,5,15 and (3) it would allow us to
manage a more homogeneous population for analysis. To
avoid methodological bias, in the analysis we only included
patients with a SCro1.4 mg/dl and ARF in organ transplant
patients was excluded. The methods used were singular with
respect to: (1) the period of inclusion, 15 years; (2) the
prolonged period of potential follow-up of the patients, from
7 to 22 years; (3) the number of patients analyzed; (4) the
small percentage of patients with unknown evolution; and
(5) the fact of studying not only the survival outcome but
also the renal functional outcome. In fact, on analyzing the
literature (Table 4) we found that: (1) the long-term follow-
up period of the patients studied is very variable, ranging
Table 3 | Analytical data of the acute tubular necrosis surviving patients in their last clinical evaluation during 2000–2001
Parametera Normal renal function (n=46) Mild renal insufficiency (n=9) Moderate renal insufficiency (n=2)
Plasma (n=57)
Creatinine (mg/dl) 1.17 0.2 1.770.1 3.371.5
Urea (mg/dl)11 45.3735.0 75.1735.7 103.0721.2
Na (mEq/l) 140.072.3 138.876.1 142.372.8
K (mEq/l) 4.470.5 4.470.3 4.670.5
Cl (mEq/l) 105.774.0 102.573.7 105.570.7
Total CO2 (mEq/l) 28.273.0 28.172.0 24.673.6
Uric acid (mg/dl) 5.971.4 6.772.2 9.273.5
Glucose (mg/dl) 115.2746.3 113.4726.2 118.2733.5
Total proteins (mg/dl) 7.370.7 7.171.3 7.670.3
Hemoglobin (g/dl) 1571.4 13.973.2 11.671.3
Hematocrit (%) 44.374.0 41.873.0 36.175.8
Urine (n=40)
Creatinine (mg/dl) 104,7749.0 71.0729.0 45.5714.8
Urea (g/l) 18.676.0 11.275.0 7.172.0
Na (mEq/l) 116.071.0 88.774.3 76.974.6
K (mEq/l) 39.071.9 30.072.2 18.072.6
Cl (mEq/l) 100.5740.0 94.6741.0 67.8735.0
Proteinuria* (mg/min) 0,4371.18 (n=12)** 0.4370.45 (n=4) 0.5470.03 (n=2)
Creatinine clearance (ml/min) 101.3726.4 (n=29) 52.1712.1 (n=9) 37.372.5 (n=2)
To convert urea to BUN values, in mg/dl, divide by 2.14.
aValues are expressed as mean7s.d.
*Means estimate only the values of patients with positive proteinuria.
**This group includes several patients with diabetes, one of them with nephrotic proteinuria.
Table 2 | Should be rebuilt as follows
Reference value Regression coefficient P HR CI
Age 0.04 0 1.038 1.02–1.06
Type of admission: 0
Surgical Medical admission 0.8 0 0.45 0.29–0.70
Trauma 0.88 0.397 0.42 0.05–3.16
Presence of Comorbidity factors Absence of comorbidity 1.46 0.006 4.29 1.51–12.17
Sex Female 0.54 0.02 1.72 1.09–2.72
CI, confidence interval; HR, hazard ratio.
Log likelihood ratio: X2=52.59; P=0.000.
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from 65 to 3721 months; (2) the follow-up was X5 years in
only four articles;1,2,8,10 and (3) only three studies included
more than 150 cases.2,9,10 Additionally, the follow-up rate in
three studies is unknown or too low to obtain solid
conclusions.4,5,7 It is of note that only one epidemiological
community-based study9 and those based either on national
civil register data,2,8 or on a ‘short’ long-term follow-up
period (12 months)6 were able to have a hundred per cent
follow-up rate. Consequently we suggest that only those
articles having a follow-up period of at least 5 years, a follow-
up rate near, or higher than 90% and a minimum of 100
patients followed-up should be considered for drawing
conclusions on the long-term outcome of ATN.
Of patients surviving an ATN episode, 50% were still alive
10 years later. These data varied in relation to some variables.
The older the age, the worse the survival rate with the
exception of the youngest group of patients where acquired
immunodeficiency syndrome, in the pre-retroviral era, or
intravenous drug abuse was present. Also, using multivariable
analysis, age was a variable having statistical influence on
long-term survival. An adverse effect of age on long-term
outcome of ARF patients has been previously reported.4,7,10
Admission type (medical, surgical, or trauma) had a
significant influence on evolution, both on comparing survival
curves and using multivariable analysis. The patients with
better survival rates were those admitted for trauma (84% at
10 years). Cox analysis identified the type of admission as a
variable with an independent predictive power; in fact, the
hazard of death of surgical patients is half that of medical
patients. Neither age, which was higher in surgical than in
medical patients (63713 years versus 54717 years;
P¼ 0.000), nor the presence of comorbidity factors (92 versus
80%, respectively in both groups) justified these findings.
As in three previous series,7,9,10 presence of comorbidity
factors in our population was associated with a worse survival
rate at 10 years than that observed in patients without
comorbidity factors (42% versus 85%). Although the patients
having comorbidity factors were older than those with out
them (60715 years versus 49720 years, respectively), the
Cox proportional model clearly shows that comorbidity
factors independently influence the long-term evolution (HR
4.29). When each of the 11 comorbidity factors considered
was individually studied we found no significant differences
in long-term survival of each group, possibly as most of the
patients had more than one comorbidity factor; and the
number of patients in some groups was too small to draw
conclusions.
Survival at 10 years of patients needing ICU admission
while presenting ARF was significantly higher than that of the
patients not requiring ICU treatment (61 versus 42%,
respectively; P¼ 0.000). However, this variable was not
identified in survival analysis with covariants, possibly
because of the influence of the other variables. In fact,
among the ICU patients there was a predominance of trauma
or surgical causes that were associated with a higher survival
rate than that of the ARF patients admitted for medical
reasons. It could be speculated that some surgical diseases
and trauma lesions could be resolved by surgery, whereas
medical diseases are more frequently associated with the
aging process. In agreement with our findings, Morgera
et al.10 found that their septic patients, who had their greatest
in-hospital mortality, had a tendency toward a better long-
term outcome after discharge.
When we analyzed the data (not shown) of the 413
patients who developed the ARF during the inclusion period,
we observed that high ISI, ICU treatment, and surgical or
trauma admission were among the variables associated with a
high rate of mortality in the initial evolution of the ARF.
However, some variables were associated with a better
probability of survival in the long-term outcome. These data
suggest that an ARF developed in a severe clinical context,
when the systemic inflammatory response syndrome is
usually observed, is associated with initial higher mortality,
but with a better long-term survival in those overcoming the
clinical episode producing ARF.
As for early mortality,13 late mortality was usually owing
to the disease for which the patient was initially admitted and
during which ARF developed. Similar data have been
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Figure 3 | (a) Graphic comparison of the survival of the patients
discharged alive after an ARF episode (red line) and a cohort of
all the Madrid in-habitants older than 15 years alive on 1.1.1978
(green line). (b) Graphic comparison of the effect of the age on
survival in patients discharged alive after an ARF episode and that of
the Madrid in-habitants alive on 1.1.1978. Solid lines represent the
survival curves of the ARF patients. Discontinuous lines represent the
survival curves of the Madrid inhabitants. Blue lines: people older
than 30 and equal or younger than 50 years. Green lines: people older
than 50 and equal or younger than 70 years. Red lines: people older
than 70 years.
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reported by Frost et al.2 Additionally, Gentric and Cledes15 in
a study of renal function after ATN in patients o 65 years,
reported that none of their patients died owing to renal
insufficiency during the long-term outcome. Although, from
our data, we could not conclude whether prevention of ATN
in patients with comorbid conditions could play a favorable
role in the long-term outcome of this condition, it seems
reasonable to implement prophylactic measures in patients in
situations of risk for developing ARF.
As in other series,11,12 renal function measured by SCr
improved during the first 6 months after discharge. After
that, SCr tended to stabilize, although with wide dispersion
in individual values. In agreement with these data, the last
clinical evaluation in 57 of our patients was satisfactory in
most cases although, at some stage during the follow-up,
1.6% of the patients required dialysis treatment.
The graphic comparison of the survival curves of the ARF
patients with the cohort of the whole adult population of the
1978 Madrid in-habitants discloses the importance of the
long-term outcome of ARF by itself. At 10 years, the survival
rate of the Madrid population was 92%, whereas that of the
ARF patients was 50%. Frost et al.2 compared the survival of
their patients with medical or surgical ARF and that of a
Danish-matched population. However their data are not
directly comparable with our results as they studied the
outcome from the moment of hospital admission, whereas
we only considered long-term outcome of patients dis-
charged alive after an ATN episode. The poorer survival of
the ARF patients in comparison with the Madrid population
cannot be attributed to age as is clearly shown in Figure 3. To
the best of our knowledge this is the first time that this type
of analysis has been reported.
Table 4 | Literature review: long-term outcomes of patients surviving an ARF
Number of
patients
(characteristics)
Period
studied ARF etiology
Survivors (n)
in-hospital
mortality (%)
Maximum
follow-up
in months
Number of
long-term
studied
patients
Follow-up
rate
Long-term
survival (%)
Functional
outcome
Turney et al.1a 142 Severe ARF 1956–1987/R Obstetric
causes
112 (21%) 372 102 91% 1 year. 79%h
5 years: 75%h
10 years: 72%h
SCrs increased:
48%
Frost et al.2b 419 (100% dialysis) 1977–1988/R 82% ATN 226 (46%) 144 226d (73%
ATN)
100% Medical ARF:
52% (5 years)g
Surgical ARF: 28%
(5 years)f
NR
Chertow et al.3b 132 ICU setting
(100% dialysis)
1991–1993/R 78% ATN 40 (70%) 12 39 97% 81%f Chronic dialysis:
33%h
Lameire et al.4b 230 ICU setting
(100% dialysis)
1993–1995/R Most ATN 79 (66%) 18 79e NA 15%g NR
Brivet et al.5c 360 ICU setting
(48% dialysis)
1991/P 78% ATN 150 (58%) 6 86 57% 87% (6 months)h SCrX1.7 mg/dl:
28%
McCarthy et al.6c 142 ICU setting
(71 patients in
each period)
1977–1979
and
1991–1992/R
480% ATN 23 (68%) 12 23 100% Period 77–79:
21%g
Period 77-79:
Chronic dialysis:
4%
480% ATN 37 (48%) 12 37 Period 91-92:
30%g
Period 91–92:
Chronic dialysis:
21%
Khan et al.7b 310
(Epidemiological –
community-based)
1989–1990/R Miscellaneous NR(?) 24 NR NA 31% (2 years)g NR
Korkeila et al.8b 62 ICU setting
(100% dialysis)
1992–1993/R ATN 34 (45%) 60 3411 100% 35% (5 years)g Chronic dialysis:
8%g
Stevens et al.9c 288
(Epidemiological –
community-based)
1996/P Miscellaneous 161 (56%) 36 161 100% 28% (3 years)g NR
Morgera et al.10b 979 (100% CRRT) 1993–1998/R Probably
mainly ATNf
301 (69%) 88 267 89% 50% (5 years)h Chronic dialysis:
10%h
Ramo´n y Cajal
Hospital
experiencea
413 General series
(48% dialysis)
1977–1992/R ATN 187 (55%) 264 177 95% 50% (10 years)h Chronic dialysis:
2%h
ATN, acute tubular necrosis; CRRT, continuous renal replacement therapy; ICU, intensive care unit; NA, not assessable; NR, not reported; P, prospective; R, retrospective;
SCr, serum creatinine.
Follow-up rate: number of long-term followed-up patients with respect to the number of patients discharged alive.
aCases with previous renal function impairment were excluded.
bPrior renal function unknown.
cIncludes patients with prior renal insufficiency.
dStill alive according to the Danish Central Personal Register.
eAccording to the Finnish National Population Register.
fPersonal interpretation of the authors’ data.
gWith respect to the initial population.
hWith respect to the patients discharged alive.
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In summary, we believe that the methodological char-
acteristics and results of this article contribute in establishing
the natural history of ARF from the introduction of renal
replacement therapy by Kolff.16 The factors conditioning the
long-term outcome are age, the disease causing the initial
admission at which ARF occurs, male sex, and the
comorbidity factors of the patients at that time.
MATERIALS AND METHODS
Selection criteria, population, and study periods
After exclusion of patients with previous impairment of their
basal renal function (SCr41.4 mg/dl), those who had received any
kind of transplantation and those younger than 15 years, we
identified 413 patients fulfilling the ATN criteria used in this article
(see below). The 187 patients discharged alive constitute the
population analyzed.
The inclusion period is 15 years, from October 1977, when our
hospital was opened, through December 1992. The follow-up period
ended on 31 December 1999. Consequently the potential observa-
tional period of the patients ranged between 7 and 22 years.
Definitions
The following concepts were defined as published previously:13,17
ARF was considered when a sudden rise in SCr to more than 2 mg/
dl (177mmol/l) was found in subjects with prior normal renal function.
ATN was diagnosed following an exclusion process when other
possible causes of ARF were eliminated. In this article ARF is
considered as synonymous with ATN.
Although ATN etiology is frequently multifactorial we classified
our patients in one of the four following etiologic groups: (1)
Surgical; (2) Nephrotoxic; (3) Septic, and (4) Medical.
Oliguria was defined as a urine outputo400 ml/24 h.
Functional severity of the ARF episode was graded as follows: (a)
mild (maximum SCrp3.0 mg/dl; (b) moderate (SCr43.0 and
p6.0 mg/dl) and, (c) severe (SCrX46.0 mg/dl).
Recovery of renal function at hospital discharge was classified as:
(a) total (SCrp1.4 mg/dl); (b) partial (SCr41.4 mg/dl and lower
than the maximum SCr reached); and (c) absence, if the SCr was
similar to the highest level observed during the ARF episode or if the
patient still needed renal replacement therapy.
Renal function during the follow-up was classified as: (1) Normal
(SCrp1.4 mg/dl); (2) mild renal insufficiency (SCr41.4 and
p2.0 mg/dl); (3) moderate renal insufficiency (SCr42.0 and
p4.0 mg/dl; (4) severe renal insufficiency (SCr44.0 mg/dl);
and (5) terminal renal insufficiency (when chronic dialysis was
needed).
Type of admission was subclassified in three categories: (1)
medical (patients hospitalized for medical diseases not, at least
initially, subsidiaries of surgery); (2) surgical (any admission due
either to emergency or elective surgery); and (3) trauma admission.
Variables recorded during ARF admission:
(1) Sex and age; (2) comorbid conditions (cardiac, hepatic and
pulmonary obstructive diseases, tumors, diabetes mellitus, hyper-
tension, acute cerebrovascular accident, peripheral arteriopathy,
aortic aneurysm, and acquired immunodeficiency syndrome); (3)
ATN etiologic groups; (4) the clinical variables needed for the ISI
calculation17 at the moment when the nephrologist saw the
patient for the first time; (5) need and type of dialysis: intermittent
hemodialysis, peritoneal, continuous renal replacement therapies,
or combinations of the previous forms; (6) the number of
dialysis sessions; (7) SCr levels: at the moment of ARF diagnosis,
the highest value during admission and at discharge; (8) need of
ICU treatment.
During this period, severity of ARF was estimated in two ways:
(1) that of the patients was calculated using the ISI,17 whereas,
(2) functional impairment was recorded as described above.
Search for long-term outcome data: operational procedure
The required information related with the long-term outcome was
obtained as summarized in Figure 4. After completing all the steps in
Figure 4, only 10 patients were lost to long-term follow-up; however
five of them had a partial follow-up ranging between 15 and 60 days
after discharge. In the case of the patients who had died outside the
hospital, information about their renal function and the date and
admission
Deaths during hospital re-Surviving 
patients (187)
Positive response
(58 patients)
Positive response
(32 patients)
Positive response
(36 patients)
Positive response
(30 patients)
Initial contact
letter/phone
(166 patients)
in the follow-up period
(21 patients)
Phone company
Social security database
Other sources of information
Second review of case records
looking for phone numbers
of relatives
No answer
(76 patients)
No answer
(10 patients)
No answer
(108 patients)
Figure 4 | Flow-chart showing the contact method and the number of patients found with each approach.
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cause of death was obtained either from their relatives or their
family doctors.
Management of the ARF
All patients with ATN treated in our department were seen by at
least one staff member (usually FL) and one resident. In addition, all
patients treated in an ICU setting were also attended by the ICU staff
together with the nephrologists. Dialysis was indicated when SCr
was X6 mg/dl and/or blood urea nitrogen 4100 mg/dl. Dialysis
and/or ultrafiltration were also used to treat hyperkalemic or
hypervolemic events. Supplements of water, proteins, calories, and
minerals, as well as inotropic support, were individually adminis-
tered as needed. The type of the dialysis membrane was not available
in the case records. In general, during the first 6 years of the study
cuprophanic membranes were predominant, but in the next 4 years
both cuprophanic and biocompatible membranes were used,
whereas during the last 5 years biocompatible membranes (poly-
sulphone and polyacrilonitrile) were used. Usually an initial
intravenous dose of 250 mg of furosemide was administered to
oliguric patients.
Final clinical evaluation. All patients alive at the end of the
follow-up period were requested, either during 2000 or 2001, to
attend our department for a complete check-up. This evaluation
included interview, physical examination and analytical tests both of
blood (hemogram, glucose, uric acid, ionograme, SCr, serum urea,
total proteins, and plasma osmolality) and urine (creatinine, urea,
natrium, kalium, chloride, glucose, proteinuria osmolality, and
urinary sediment). Additionally, Creatinine clearance was calculated
by an 8-h urine collection.
Comparison of the survival rates of ARF patients and the
Madrid general population. The survival curve of our patients
was graphically compared with that of a cohort, the Madrid
population older than 14 years, alive on 1 January 1978. This date
was chosen as October 77 was the date of the inclusion of our first
patient in the study. The effect of age on survival, both in ARF
surviving patients and in the whole population of Madrid, was also
analyzed using a similar approach. The survival curves of the normal
population were performed using the Mortality Tables of the Madrid
Community (years, 1978–1999) of the ‘Instituto de Estadı´stica de la
Comunidad de Madrid’ (unpublished data).
Statistical analysis
Continuous variables were summarized by mean and standard
deviation. Categorical variables were summarized using absolute
values or proportions. Survival curves were estimated by the
Kaplan–Meier method and differences between curves assessed with
the log-rank test. Multivariate survival analysis was performed by
the Cox model. The log-likelihood ratio test was used for model
comparison and goodness of fit assessment. The final, most
parsimonious model was obtained by backward selection from the
maximal model composed by ten variables: age, sex, type of
admission, ATN etiology, Need of dialysis, ARF functional severity,
oliguria, ICU admission, level of renal function recovery at
discharge, and incidence of comorbidity factors. Multinomial
variables were coded by dummy variables. Statistical analysis was
performed using SPSS version 10.0.
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